News

Japanese radiologist Katsumi Nakamura, M.D., of Tobata Kyoritsu Hospital, received first place honors for his research in the area of non-contrast magnetic resonance angiography (MRA) imaging at the 14th annual International Society for Magnetic Resonance in Medicine (ISMRM) Scientific Meeting & Exhibition.

Home September 18, 2006
Home
News

The FDA has approved Medtronic’s Adapta portfolio of fully automatic pacemakers. The system provides physiologic pacing ...

Home September 18, 2006
Home
News

Enrollment is complete for a landmark study designed to increase clinical understanding of vulnerable plaque, the deadly, lipid-rich coronary plaque that ruptures without warning or symptoms and possibly the source of most heart attacks.

Home September 18, 2006
Home
News

Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor Cardiologists were urged to halt the "epidemic of madness" behind drug-eluting stent (DES) overuse, during an address by Salim Yusuf, M.D., McMaster University, Hamilton, Ontario, at the World Congress of Cardiology in Barcelona.

Home September 18, 2006
Home
News

Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent System were presented at the World Congress of Cardiology conference in Barcelona, Spain. XIENCE V, which has received CE Mark approval, is currently an investigational device in the U.S. and Japan — Abbott says it plans to initiate European launch of the coronary DES in October.

Home September 18, 2006
Home
News

Thousands of lives potentially saved and hospital costs reduced are the predicted outcomes if more hospitals adopt certain quality measures on a wider scale, according to an analysis by Premier Inc. healthcare alliance, headquartered in San Diego, which is owned by more than 200 of the nation's leading not-for-profit hospitals and healthcare systems.

Home September 18, 2006
Home
Feature | Ryan Hiett

It may seem like a simple concept, but the importance of properly controlled patient temperature is still surprising ...

Home September 12, 2006
Home
Case Study | Kishor N. Vora, MD., Interventional Cardiologist, Owensboro Medical Health System, Owensboro, Kentuc

Targeted Renal Therapy (TRT) with the Benephit CV Infusion System from FlowMedica Inc. is an alternative to systemic intravenous (IV) infusion of medications to address kidney dysfunction related to a number of conditions. TRT is a novel technology that enables the infusion of medications and other therapeutic agents directly into the kidneys via the renal arteries.

Home August 29, 2006
Home
Technology

Abiomed Inc. recently announced the start of the IMPELLA 2.5 pilot study in the U.S. with the enrollment of the first ...

Home August 29, 2006
Home
Technology

A software fusion application that enables clinicians to perform multimodality image fusion in a single application ...

Home August 29, 2006
Home
Technology

OXILAN (Ioxilan Injection) is a contrast media for use in peripheral procedures because of its viscosity. Its reportedly ...

Home August 29, 2006
Home
Feature | Judy Hostert-Harvey

Having the most up-to-date blood gas readings is critical when dealing with many patients, especially pulmonary and ...

Home August 29, 2006
Home
Feature | Kim Phelan

Five million Americans are affected by heart failure and approximately 400,000 new cases in the U.S. are diagnosed each year, according to the Heart Failure Society of America — that figure quadruples globally, and many do not know they have a heart failure condition until they are hospitalized.

Home August 29, 2006
Home
Technology

The Relay 250-mm thoracic stent-graft is commercially available in Europe in both straight and taper configurations. The ...

Home August 29, 2006
Home
Technology

The EXCOR TAH-t has received CE approval with the CardioWest TAH-t. The pneumatic drivers provide precisely calibrated ...

Home August 29, 2006
Home
Subscribe Now